Research And Development
Upcoming Earnings
Europe
AstraZeneca
$40.589876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$40.58
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.25 (0.62%) Today
$0.00 (0.00%) As of 4:40 PM EDT after-hours
Why Robinhood?
You can buy or sell AstraZeneca and other stocks, options, ETFs, and crypto commission-free!
About AZN
AstraZeneca PLC, also called AstraZeneca, is a holding company, which engages in the research, development and manufacturing of pharmaceutical products. The company produces and commercializes medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology, and infectious diseases. Read More Its pipeline consists of azd 4831, azd 8601, medi 6012, tagrisso bloom, durvalumab, selumetinib, lyparza polo, epanova, farxiga and brilinta. The company distributes its products under the following brands: Atacand, Crestor, Onglyza, Nexium, Entocort, Losec, Merrem/Meronem, Carbocaine, Citanest, Diprivan, Marcaine/Sensorcaine. AstraZeneca was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Employees
64,400
Headquarters
Cambridge, Cambridgeshire
Founded
1992
Market Cap
102.28B
Price-Earnings Ratio
42.55
Dividend Yield
3.61
Average Volume
2.46M
High Today
$40.89
Low Today
$40.46
Open Price
$40.66
Volume
4.12M
52 Week High
$43.30
52 Week Low
$35.30
Collections
Research And Development
Upcoming Earnings
Europe
Health
Manufacturing
Cancer Prevention
Biotechnology
Medical
AZN News
Price Paid on Robinhood
11% Higher
Right Now
52 Week Low
$34.38
Average Price Paid
$36.55
52 Week High
$43.30
Analyst Ratings
62%
of 26 ratings
Buy
62%
Hold
27%
Sell
12%
AZN Earnings
$0.29
$0.72
$1.15
$1.58
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
$0.29 per share
Actual
Available Jul 25, Pre-Market